Vinod Sharma

9PUBLICATIONS
57CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursDisease surveillanceTransplantation immunologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 24, 2025
Olanzapine Versus NK1 Receptor Antagonist for Prevention of Carboplatin-Induced (AUC ≥4) Emesis: A Phase III, Double-Blind, Placebo-Controlled Randomized Trial From India.

Sneh Bhargave, Vinod Sharma, Babita Kataria

|Dec 05, 2024
Gemcitabine Cisplatin and Durvalumab Experience in Advanced Biliary Tract Cancers: A Real-World, Multicentric Data From India.

Vamshi Krishna Muddu, Anjali Shah, Anupa John

|Nov 14, 2024
Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer: A Multicenter, Randomized, Double-Blind, Phase III Trial.

Kumar Prabhash, Chetan Deshmukh, Hemant Malhotra

|Feb 27, 2024
Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial.

Akhil Santhosh, Atul Sharma, Sameer Bakhshi

|Feb 22, 2024
SMART-ESAS: Smartphone Monitoring and Assessment in Real Time of Edmonton Symptom Assessment System Scores for Patients With Cancer.

Chitrakshi Nagpal, Atul Sharma, Sameer Bakhshi

|May 13, 2022
Long-Term Outcomes and Safety Trends of Autologous Stem-Cell Transplantation in Non-Hodgkin Lymphoma: A Report From A Tertiary Care Center in India.

Sudhir Kumar, Atul Sharma, Raja Pramanik

Pageof 2

Frequent Collaborators

5 joint publications

Raja Pramanik

3 joint publications

Prabhat Singh Malik

3 joint publications

Atul Batra

3 joint publications

Sameer Bakhshi